Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

In a bold move that’s redefining crypto’s relationship with traditional finance, MEI Pharma, a Nasdaq-listed company known ...

GSR announced an investment and strategic partnership with MEI Pharma in which it will serve as both strategic advisor and ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied ...

GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc.

U.S. spot Ethereum ETFs command $20.66 billion in ETH, or 4.64% of its market cap. Bitcoin investment product inflows have ...

Litecoin (LTC) price extends its recovery, trading at around $104 on Friday, after breaking above $100 for the first time in nearly two months. Institutional demand for LTC is increasing, reflected by ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.